The eleven categories of the awards include “Producer of the Year”, “Distributor of the Year” and “Non-profit of the Year”. Some 20 experts from the medical cannabis industry will assess the nominations and select three finalists for each category. Another nine judges will pick the winners out of the shortlisted top three.

Furthermore, the ceremony is combined with a charity dinner hosted by SiGMA Group, the organiser of the Malta Medical Cannabiz Summit. The fund-raiser will auction a selection of artworks with all proceeds going to the SiGMA Foundation and SavingSophie.org, which is a medical cannabis-related charity supporting care treatment for Sophie Ryan and other young cancer sufferers who can benefit from medical cannabis treatments.

The post Malta Medical Cannabis Awards opens for nominations first appeared on The Malta Business Weekly.

The inaugural show of Medical Cannabiz World will be held in Malta in November 2019. The event in Thailand scheduled for June 2020 aims to bring together the world of medical cannabis production and distribution focussing on the “East and West igniting this new and high-growth sector”.

SiGMA Group has recently signed a Memorandum of Understanding (MoU) with Thailand’s Rangsit University, SiGMA Group hopes will help facilitate its expansion in Asia.

The Asian cannabis market is expected to be worth US$5.8b by 2024 if both medical cannabis and recreational cannabis are legalised across a number of key markets, such as Thailand, China, India, and South Korea, the Asia Cannabis Report published by Prohibition Partners reveal.

The report by Prohibition Partners adds that Thailand, Singapore and China are all pursuing research into the healthcare applications of cannabis. This very same report says that Thailand — together with Malaysia, Sri Lanka, Singapore and South Korea — is “at the vanguard of change in the region”.

At the same time, Thailand, South Korea, Malaysia and Singapore are considered to be leading the way in regulation and legislation, although other countries such as Myanmar have softened their approach to drug crime, the report says.

“There is so much opportunity for the medical cannabis sector around the globe at the moment. As SiGMA Group expands operations from Europe to the East with both the SiGMA iGaming conference and the AIBC Summit, it makes sense to exploit the growing sector for medical cannabis businesses in the region,” said Eman Pulis, SiGMA Group founder and CEO.

The post SiGMA adds Thailand to Medical Cannabiz World calendar in 2020 first appeared on The Malta Business Weekly.

More than 2,000 delegates have confirmed to arrive for the networking event that might see brokering deals and discussing the important issues defining the sector, including legislation, education, investment, and technology. 

The inaugural edition of Medical Cannabiz World will welcome the medical cannabis sector that boasts of potential as the Maltese government has recently passed legislation supporting its commitment to the vertical.  

The summit will host exhibitors, brands from across the industry, production, logistics, payment processing, know your customer (KYC), legal and regulatory. 

The summit will also focus on the regulatory benefits for businesses setting up in Malta, attracting investors, medical researchers, policymakers and entrepreneurs looking to forge exciting new opportunities. 

“This is another huge milestone for both Malta and the wider business community involved in the life-changing medical cannabis industry.  With Malta’s new regulatory environment in this area, we are seeing a significant number of companies coming to the island to take part in the summit, many of which are either looking for angel funding from early-bird investors or are offering investment opportunities,” said Eman Pulis, Founder and CEO of SiGMA Group.   

In addition, Medical Cannabiz World is part of Malta Week, featuring the Malta AI and Blockchain Summit on 7-8 November.

The post Malta to host first Medical Cannabiz summit first appeared on The Malta Business Weekly.